Geltrude Mingrone

Professor of Diabetes and Nutrition, King’s College London

Medical doctor, specialist in Endocrinology and in Gastroenterology. Associate Professor of Internal Medicine at the Catholic University in Rome and Professor of Diabetes and Nutrition at the King’s College London. I am working actively to study the mechanisms of remission of type 2 diabetes after metabolic surgery. I published RCTs in diabetes and metabolic surgery. I am PI in SOPHIA an Innovative Medicine Initiative project involving European scientists and major pharmaceutical companies to understand the determinants of obesity and of the response to different obesity treatments. I am taking part of the board of the Lancet Obesity Commission.

Sessions

10-Nov-2021

09:45– 10:20
Innovation and evaluation of surgery in research

“Future Surgery 2021 will be the first of its kind in the UK, drawing on the work our Commission on the Future of Surgery has done to predict the transformation in the medical care for millions of patients.”
Andrew Reed, Chief Executive of the Royal College of Surgeons of England
“Driven by changes in digital technologies and our fast-evolving understanding of genomics, innovations are expected to affect how we undertake surgery, and how we train surgeons in future.”
Andrew Reed, Chief Executive of the Royal College of Surgeons of England
"Alongside the conference organisers, CloserStill, we aim to deliver a high-quality event that will provide both professional development and discussion space for surgeons and their teams."
Andrew Reed, Chief Executive of the Royal College of Surgeons of England
"We look forward to welcoming colleagues to what promises to be a very high-quality programme and an exciting two days of thought-provoking training and engagement with medical suppliers."
Andrew Reed, Chief Executive of the Royal College of Surgeons of England